BMJ journal deems opioid dependency implant more favourable than tablets
While the opioid epidemic in the USA is well documented, Europe also has an estimated 1.3 million high-risk opioid users.
Read More
Tag: buprenorphine
EU nod for opioid dependence therapy
The European Medicines Agency has issued a marketing authorisation for Orexo and MundiPharma’s Zubsolv (buprenorphine and naloxone) for opioid dependence.
Read More
Appeal court paves way for launch of Sandoz’ Reletrans
Novartis’ generics arm Sandoz is launching its long-acting buprenophine patch Reletrans in the UK following victory in a patent battle with Napp Pharmaceuticals.
Read More
US OKs first implant for opioid addiction
US regulators have approved the first buprenorphine implant to help treat people addicted to opioids, including prescription painkillers and heroin.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
